Product Name:

PD-0332991(Palbociclib, PF-0332991, PF-332991)

CAT#: A-1030    

Chemical Structure


Price of PD-0332991(Palbociclib, PF-0332991, PF-332991)

We offer a substantial discount on larger orders,
please inquire via
or Fax: 1-201-884-1288(USA Fax#)

We match the lowest price on market.

Biological Activity

An orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. PD-0332991 selectively inhibits cyclin-dependent kinases (particularly Cdk4/cyclin D1 kinase), which may inhibit retinoblastoma (Rb) protein phosphorylation; inhibition of Rb phosphorylation prevents Rb-positive tumor cells from entering the S phase of the cell cycle (arrest in the G1 phase), resulting in suppression of DNA replication and decreased tumor cell proliferation.
Technical Data

CAS #:827022-32-2
M.Wt: 484.01
Storage Conditions :Room temperature, or -20ºC for 2 year.

1.Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
Oncogene 29, 4018-4032 (15 July 2010) | doi:10.1038/onc.2010.154